DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today filed its second quarter Form 10-Q and reported its financial results. The report disclosed that the company’s revenues increased both for the quarter and year to date. Some of the results highlighted by the report are as follows:
Revenues for the quarter increased $279,691 or 15.7% vs. the prior year’s comparable quarter
Revenues for the quarter increased $279,691 or 15.7% vs. the prior year’s comparable quarter
